期刊文献+

HPLC检测白血病细胞系CYP3A5活性方法的建立与应用 被引量:1

Development and Application of HPLC Assay for Measuring CYP3A5 Activities in Leukemia Cell Lines
下载PDF
导出
摘要 目的建立白血病(AL)细胞系CYP3A5活性检测方法,研究化疗药对其活性的调控。方法HPLC法检测药物干预后AL细胞系CYP3A5活性。结果以1×106细胞、氢化考的松终浓度100μmol/L、孵育24h为AL细胞体外培养条件下氢化考的松6β-羟化活性检测的孵育条件。K562细胞CYP3A5活性显著高于HL-60、NB4和Jurkat细胞。柔红霉素作用24h后K562细胞CYP3A5活性增高,48h后活性显著增高;而NB4与Jurkat细胞在其作用后活性无改变。地塞米松作用24h后Jurkat细胞CYP3A5活性显著增高,48h后活性又显著增高。全反式维甲酸作用24h后NB4细胞CYP3A5活性显著增高,72h后活性又显著增高。结论HPLC检测AL细胞体外培养条件下氢化考的松6β-羟化活性方法的建立可用于研究AL细胞CYP3A5活性。柔红霉素、地塞米松、全反式维甲酸的应用可诱导某些AL细胞株CYP3A5活性。 Objective To develope HPLC assay to study CYP3A5 activities regulated by anticancer drugs in leukemia cell lines. Methods CYP3A5 activities of intact leukemia cell lines were detected through HPLC assay. Results 1×10 6 cells incubating with hydrocortisone (HC, final concentration 100 μmol/L) for 24 h were finally determined as the incubation conditions for assessing activities of HC 6β-hydroxylation in intact leukemia cell lines. CYP3A5 activity of K562 cells was statistically significantly higher than that of HL-60, NB4 and Jurkat cells. Treatment with daunorubicin increased CYP3A5 activity after 24 h in K562 cells, and further increased a statistically significantly higher activity after 48 h, while there were no remarkable changes in NB4 and Jurkat cell lines. Dexa- methasone induced a statistically significantly increased CYP3A5 activity after 24 h in Jurkat cells and statistically a even more significantly higher activity after 48 h. All-trans retinoic acid significantly increased CYP3A5 activity after 24 h in NB4 cells statistically, and induced a even more statistically significantly higher activity after 72 h. Conclusion Development of HPLC assay for measuring activities of HC 6β-hydroxylation in intact leukemia cell lines can be used to determine the localized CYP3A5 activities in leukemia cells.Treatment with daunorubicin, dexamethasone and all-trans retinoic acid induced CYP3A5 activities in some leukemia cell lines.
出处 《上海第二医科大学学报》 CSCD 北大核心 2005年第5期440-442,446,共4页 Acta Universitatis Medicinalis Secondae Shanghai
基金 国家自然科学基金(30400183)资助项目.
  • 相关文献

参考文献9

  • 1王婷,陈芳源,韩洁英,邵念贤,欧阳仁荣.CYP3A5参与急性白血病耐药机制的研究[J].中华血液学杂志,2003,24(6):286-289. 被引量:17
  • 2Raeissi SD, Guo Z, Dobson GL, et al. Comparison of CYP3A activities in a subclone of caco-2 cells (TC7) and human intestine[ J ],Pharm Res, 1997, 14:1019-1025.
  • 3Engman HA, Lennernas H, Taipalensuu J, et al. CYP3A4,CYP3A5, and MDR1 in human small and large itestinal cell lines suitable for drug transport studies [ J ]. J Pharm Sci, 2001, 90:1736 - 1751.
  • 4Das YU. Preliminary approach of the chemosensitive test in acute adult leukemia patients using microculture tetrezolium (MTT) assay [J]. J Exp Clin Cancer Res, 1994. 18:385-389.
  • 5Hukkanen J, Vaisanen T, Lassila A, et al. Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells[J]. J Pharmacol Exp Ther, 2003, 304:745 -752.
  • 6Marill J, Cresteil T, Lanotte M, et al. Identification of human cytochrome P450s involved in the fomlation of all-trans-retinoic acid principal metaholites[ J ]. Mol Pharmaeol, 2000, 58 : 1341 - 1348.
  • 7Lampen A, Meyer S, Arnhold T, et al. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes[ J ]. J Pharmacol Exp Ther, 2000, 95 : 979 - 985.
  • 8Jones SA, Moore LB, Shenk JL, et al, The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution[J]. Mol Endocrinol, 2000, 14: 27-39,.
  • 9Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions[J].J Clin Invest, 1998, 102: 1016- 1023.

二级参考文献3

  • 1Kuehl P;Zhang J;Lin Y.Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression[J],2001(4).
  • 2Lamba JK;Lin YS;Schuetz EG.Genetic contribution to variable human CYP3A-mediated metabolism[J],2002(10).
  • 3De Wildt SN;Kearns GL;Leeder JS.Cytochrome P450 3A: ontogeny and drug disposition[J],1999.

共引文献16

同被引文献13

  • 1KUEHL P, ZHANG J, LIN Y, et al. Sequence diversity in CYP'3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression [J]. Nat Genet,2001, 27 (4) : 383-391.
  • 2FUKUEN S, FUKUDA T, MAUNE H, et al. Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and * 6, in a Japanese population[J].Pharmacogenetics,2002, 12(4) :331-334.
  • 3JOUNAIDI Y, HYRAILLES V, GERVOT L, et al. Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein[ J]. Biochem Biophys Res Commun, 1996, 221 (2) :466-470.
  • 4KIM K A, PARK P W, LEE O J, et al. Effect of CYP3A5 * 3 genotype on the pharmacokinetics and phannacodynamics of amlodipine in healthy Korean subjects [ J ]. Clin Pharmacol Ther, 2006, 80 (6) :646-656.
  • 5PARK JY,KIM KA,PARK PW,et al. Effect of CYP3A5 * 3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects [ J ]. Clin Pharrnacol Ther,2006, 79 ( 6 ) : 590- 599.
  • 6BOCHUD M,EAP C B, ELSTON R C,et al. Association of CYP3A5 genotypes with blood pressure and renal function in African families [ J ]. J Hypertens, 2006, 24 ( 5 ) : 923-929.
  • 7QUARANTA S, CHEVALIER D, BOURGAREL-REY V,et al. Identification by single-strand conformational polymorphism analy-sis of known and new mutations of the CYP3A5 gene in a French po-pulation [ J ]. Toxicol Lett, 2006, 164 ( 2 ) : 177-184.
  • 8DAI Y,IWANAGA K, LIN Y S, et al. In vitro metabolism of cyclosporine A by human kidney CYP3A5 [ J]. Biochem Pharmacol, 2004, 68(9) :1889-1902.
  • 9ZHENG H, WEBBER S, ZEEVI A, et al. Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms [ J ]. Am J Transplant, 2003, 3 ( 4 ) : 477- 483.
  • 10RAEISSI S D, GUO Z, DOBSON G L,et al. Comparison of CYP3A activities in a subclone of caco22 cells ( TC7 ) and human intestine [J]. PharmRes,1997, 14(8) :1019-1025.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部